期刊文献+

免疫抑制剂对甲亢患者外周血白细胞糖皮质激素受体的调节作用 被引量:1

下载PDF
导出
摘要 目的:观察3种免疫抑制剂地塞米松(Dex)、环磷酰胺(CTX)、环孢素A(CsA)单用或合用对甲状腺功能亢进(甲亢)患者外周血糖皮质激素受体(GR)的调节作用。方法:选取甲亢患者90例,随机分成3组,每组30例,分别为Dex(A组)、Dex+CTX(B组)和Dex+CTX+CsA(C组),每周甲状腺局部注射1次,共10次。外周血白细胞GR测定采用放射配体结合法。
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第5期565-565,共1页 Academic Journal of Second Military Medical University
  • 相关文献

同被引文献17

  • 1Chung Y J, Lee B W, Kim J Y,et al. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients[J]. Thyroid,2006, 16(12):1251-1257.
  • 2Lee B C, Kang S I, Ahn Y M,et al. An alternative therapy for graves' disease: clinical effects and mechanisms of an herb al remedy[J]. Biol Pharm Bull,2008, 31(4) : 583-587.
  • 3Tanikawa T, Okada Y, Tanaka Y. Intravenous cyclophosphamide pulse therapy is effective for refractory Graves' ophthalmopathy[J]. J UOEH,2006, 28(2): 185-191.
  • 4Ozata M,Bolu E, Sengul A, et al. Effects of octreotide treat ment on Graves' ophthalmopathy and circulating sI CAM-1 levels[J]. Thyroid, 1996,6(4) : 283-288.
  • 5Panteris V, Kouroumalis E. Somatostatin and inflammation. Progress in neuropeptide research[C]. USA, Novs Science Publishers Inc,2007 : 151-174.
  • 6Krassas G E, Bohoridis K. Recent developments in the medical treatment of thyroid eye disease[J]. Orbit, 2006, 25(2): 117-15:2.
  • 7Pasquali D, Vassallo P, Esposito D, et al. Somatostatin recep tor gene expression and inhibitory effects of octreotide on pri mary cultures of orbital fibroblasts from Graves' ophthalmopathy[J]. J Mol Endocrinol, 2000,25 ( 1 ) : 63-71.
  • 8Garrity J A,Bahn R S. Pathogenesis of Graves ophthalmopathy: implications for prediction, prevention, and treatment[J]. Am J Ophthalmol, 2006, 142(1):147-153.
  • 9Stan M N, Garrity J A, Bradley E A, et al. Randomized, double blind, placebo controlled trial of long aeting release octreotide for treatment of Graves' opbthalmopathy[J]. J Clin Endocrinol Metab,2006, 91(12): 4817-4824.
  • 10Chang T C,Liao S L. Slow release lanreotide in Graves' oph thalmopathy: a double-blind randomized, placebo-controlled clinical trial[J]. J Endocrinol Invest, 2006, 29(5):413-422.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部